AYR Wellness: Management Expects 'Significant Sales' And 'EBITDA Ramp' In 2022
The Analyst
Pablo Zuanic from Cantor Fitzgerald kept a rating of "Neutral" on Ayr Wellness Inc. (OTC: AYRWF) stocks and lowered its 12-month price target to $6.75 from $13.30, due to reduced estimates and overall sectoral derating.
